Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04837846 · ClinicalTrials.gov registry record
Multicenter Study Into Individualized Scanning for Coronary Artery Disease
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 60
- Enrollment target
NCT04837846: Completed study, sponsored by Medical University of South Carolina.
NCT04837846 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04837846 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
To evaluate intravascular attenuation of the coronary arteries and image quality in an individualized scan and CM injection protocol whereas both scan and injection parameters are tailored to the individual patient in a North American, European and Asian patient population. To evaluate the radiation dose and contrast media dose of this individualized approach for CCTA in an American, European and Chinese patient population. To evaluate the injection parameters required for an average American, European and Chinese patient population.
Primary Outcome
To measure the amount of Hounsfield units in different anatomical structures produced by an amount of contrast media. Using Hounsfield units coupled with image quality to determine if a scan of diagnostic value has been attained.
Interventions
- OTHER Differing Tube Voltage Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2024-04-05 |
What the finished NCT04837846 record still lists
NCT04837846 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Differing Tube Voltage Administration is the first listed.
NCT04837846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04837846 about?
NCT04837846 is a clinical study titled "Multicenter Study Into Individualized Scanning for Coronary Artery Disease". To evaluate intravascular attenuation of the coronary arteries and image quality in an individualized scan and CM injection protocol whereas both scan and injection parameters are tailored to the individual patient in a North American, European and Asian patient population. To evaluate the radiatio...
What is the current status of trial NCT04837846?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-03-29. Estimated completion is 2024-04-05.
What interventions are being tested in trial NCT04837846?
The interventions under investigation include: Differing Tube Voltage Administration (OTHER).
Who is sponsoring clinical trial NCT04837846?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI